Study on immunogenicity and safety of a meningococcal ACYW conjugate vaccine in healthy infants and toddlers

Trial Identifier: MEQ00089
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: March 2024
Primary Completion Date: November 2025
Study Completion Date: November 2025
Condition: Meningococcal Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Czech Republic Ceske Budejovice, Czech Republic
Czech Republic Ceske Budejovice, Czech Republic, 370 06
Czech Republic Prague, Czech Republic
Denmark Aalborg, Denmark
Denmark Aarhus, Denmark
Denmark Herlev, Denmark
Denmark Odense, Denmark
Denmark Zeeland, Denmark
DENMARK Hjørring, DENMARK, 9800
Finland Espoo, Finland
Finland Helsinki, Finland
Finland Jaarvenpa, Finland
Finland Oulu, Finland
Finland Tampere, Finland
Finland Turku, Finland
FINLAND Kokkola, FINLAND, 67100
Germany Erfurt, Germany
Germany Herxheim, Germany
Germany Huerth, Germany
Germany Moenchengladbach, Germany
Germany Schoenau am Koenigssee, Germany
Germany Schweigen- Rechtenbach, Germany
Germany Wolfsburg, Germany
GERMANY Worms, GERMANY, 67550
Poland Bydgoszcz, Poland
Poland Krakow, Poland
Poland Leczna, Poland
Poland Lomianki, Poland
Poland Lubon, Poland
Poland Siemianowice, Poland
Poland Torun, Poland
Poland Trzebnica, Poland
Poland Warszawa, Poland
Poland Wroclav, Poland
Poland Wroclaw, Poland
Poland, Kujawsko-pomorskie Bydgoszcz, Kujawsko-pomorskie, Poland, 85-079
Romania Bucuresti, Romania
Romania Bucuresti, Romania, 011025
Romania Calarasi, Romania
ROMANIA Bucuresti, ROMANIA, 021105